Lipocine
LPCN
LPCN
45 hedge funds and large institutions have $16.6M invested in Lipocine in 2023 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 9 increasing their positions, 11 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
18% less repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 11
40% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 10
Holders
45
Holding in Top 10
–
Calls
$65K
Puts
$1K
Top Buyers
| 1 | +$8.07M | |
| 2 | +$39.2K | |
| 3 | +$25.2K | |
| 4 |
CA
Carson Advisory
Athens,
Georgia
|
+$16.5K |
| 5 |
Jane Street
New York
|
+$7.75K |
Top Sellers
| 1 | -$134K | |
| 2 | -$63K | |
| 3 | -$31.9K | |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
-$18.3K |
| 5 |
MFG
Merit Financial Group
Alpharetta,
Georgia
|
-$11.9K |